November 2025 Danny A. Mammo MD Cole Eye Institute, Cleveland Clinic Cleveland, OH Szeto SKH, Lam JTW, Yu AHY, et al. Ophthalmology Retina. Online ahead of print June 13, 2025. doi:10.1016/j.oret.2025.06.005 Macular hole (MH) repair has long leaned on intraoperative gas tamponade and strict postoperative positioning to support closure and healing. This study challenges that […]
November 2024 Monique Munro MD FRCSC University of Calgary, Section of Ophthalmology Calgary Alberta Strawbridge J, Cheng JY, Gundlach BS, Gillespie T, Karmouta R, Khitri M, Chu A, Tsui I. Short-term reactivation of retinopathy of prematurity after primary ranibizumab treatment. Retina. 2024 Nov 1;44(11):1945-1951. Current treatment options for Type 1 retinopathy of prematurity (ROP) includes […]
September 2024 Hasenin Al-khersan M.D. Retina Consultants of Texas Houston, TX Sherif NA, Hoyek S, Wai K, Makhoul KG, Bitar R, Tieger M, Lorch AC, Patel NA, Armstrong GW. Recovery of Vision in Open Globe Injury Patients with Initial No Light Perception Vision. Ophthalmol Retina. 2024 Jul;8(7):617-623. Open-globe injuries (OGI) consist of full thickness […]
August 2024 Kapil Mishra M.D. Gavin Herbert Eye Institute University of California, Irvine Wiley HE, Srinivasan R, Maranchie JK, et al. Oral hypoxia-inducible factor 2α inhibitor belzutifan in ocular von hippel-lindau disease. Ophthalmology. Published online June 2024:S0161642024003191. Von Hippel-Lindau (VHL) disease is a hereditary condition characterized by the development of tumors in multiple organs […]
May 2024 Joshua Uhr MD Retinal & Ophthalmic Consultants Northfield, NJ Pandit SA, Momenaei B, Wakabayashi T, Mansour HA, Vemula S, Durrani AF, Pashaee B, Kazan AS, Ho AC, Klufas M, Regillo C, Yonekawa Y, Hsu J, Kuriyan A, Chiang A. Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration. […]
May 2024 Samir N. Patel, MD Retina Vitreous Consultants, Pittsburgh PA Ton NS, Goncharov V, Zapata I, Adam MK. Endophthalmitis after Anti-VEGF Intravitreal Injections with Aqueous Chlorhexidine versus Povidone-Iodine as Ocular Antiseptics. Ophthalmol Retina. 2023 Dec 18:S2468-6530(23)00648-6. PMID: 38122867. Infectious endophthalmitis is a rare but potentially severe complication of intravitreal injections. Multiple strategies have […]
February 2024 Matt R. Starr, MD Vitreoretinal Surgery Mayo Clinic Rochester, MN Rachel N. Israilevich, MD, Hana Mansour, MD, Samir N. Patel, MD, Sunir J. Garg, MD FACS, Michael A. Klufas, MD, Yoshihiro Yonekawa, MD, Carl D. Regillo, MD FACS, Jason Hsu, MD. Risk of Endophthalmitis Based on Cumulative Number of Anti-Vascular Endothelial Growth […]
February 2024 Jordan D. Deaner, MD Uveitis and Vitreoretinal Surgery Mid Atlantic Retina, Wills Eye Hospital Assistant Professor, Thomas Jefferson University Philadelphia, PA Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee:; Acharya NR, Vitale AT, Sugar EA, Holbrook JT, Burke AE, Thorne JE, Altaweel MM, Kempen JH, Jabs DA. Intravitreal Therapy for […]
